News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Alexion Pharmaceuticals Inc. Reports Third Quarter 2010 Results
October 21, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced financial results for the three and nine months ended September 30, 2010.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Alexion
MORE ON THIS TOPIC
Business
Genentech culls 103 jobs, inks $490M-plus biobucks deal with Astex
July 6, 2026
·
2 min read
·
Gabrielle Masson
Layoff Tracker
Genentech, BioNTech cut over 100 roles each
July 6, 2026
·
66 min read
·
BioSpace Editorial Staff
IPO
Early-stage Scribe wants to write IPO story even as investors favor derisked portfolios
July 6, 2026
·
2 min read
·
Tristan Manalac
China
AstraZeneca taps China’s CSPC again, betting up to $1.77B to target kidney diseases
July 2, 2026
·
2 min read
·
Tristan Manalac
